Prostate Cancer Detection Improved by Accounting for Genetics that Cause PSA Level Variations
PSA screening for prostate cancer could be improved by accounting for genetic factors that cause PSA changes not associated with cancer.
Read MorePosted by Andy Lundin | Apr 12, 2022 | Prostate |
PSA screening for prostate cancer could be improved by accounting for genetic factors that cause PSA changes not associated with cancer.
Read MorePosted by Chris Wolski | Apr 8, 2022 | Sexually Transmitted Diseases |
M. Genitalium testing is difficult, but the approval of a NAAT for the diagnosis of this STI will help protect patient fertility.
Read MorePosted by Andy Lundin | Apr 5, 2022 | Cardiovascular |
When exactly patients should undergo genetic assessment for a heart condition was recently detailed in an international consensus document.
Read MorePosted by Chris Wolski | Apr 5, 2022 | Specimen Collection & Handling |
Dried blood spot testing provides clinical labs an easy-to-collect, reliable, and cost-effective means to test for a variety of diseases.
Read MorePosted by Andy Lundin | Mar 24, 2022 | Covid 19 |
Thermo Fisher Scientific will help develop a new genotyping method for SARS-CoV-2 that could speed up the identification of new variants.
Read More